课题基金 / 基金详情

CAP-IT CRI U54 ADMINISTRATIVE CORE

CAP-IT CRI U54 ADMINISTRATIVE CORE
CAP-IT CRI U54 管理核心
批准号:
10505676
负责人:
Steven M Lipkin
金额:
$11.71万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31

项目摘要

项目成果

Steven M Lipkin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Admin Core: Project Summary/Abstract A significant overall goal of CAP-IT is to identify and validate immunologically targeted agents for precision prevention of individuals with increased cancer risk. The CAP-IT Center for RNA Immunoprevention (CRI) Administrative Core (AC) mission is to ensure that research project/Core teams maintain focus on this overall goal. The AC will rapidly perform administrative functions that would otherwise serve as rate-limiting bottlenecks, including IRB/IACUC regulatory compliance and the establishment of MTA/DTAs between multiple project sites. The AC will integrate CRI U54 into the CAP-IT network and drive intra-network as well as international collaborations. To ensure CRI's scientific rigor and excellence, we have assembled a scientifically and administratively outstanding CRI External Advisory Board, including the 2021 Lasker Award winner Dr. Drew Weissman (U. Penn). The AC shall also seamlessly integrate genomic databases and emerging technology as shared resources (such as liponanoparticle RNA vaccines and immunopeptidomics) with the CAP-IT U24 DRCC. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lynch Vaccine
Cancer Immune-Interception for Lynch Syndrome
Cancer Immune-Interception for Lynch Syndrome
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
海外基金